Development of clinical dosage forms for a poorly water soluble drug I: Application of polyethylene glycol-polysorbate 80 solid dispersion carrier system.

Different formulation approaches were evaluated to ensure that the formulation of a poorly water soluble compound chosen during early development achieves optimum bioavailability. The insoluble compound has an aqueous solubility of 0.17 micro g/mL at 25 +/- 1 degrees C, a relatively high permeability (Caco2 P(app) = 6.1 x 10(-4) cm/min), and poor bioavailability in dogs (dry blend formulation). Based on the prediction by GastroPlus, the oral absorption of this compound is sensitive to its apparent solubility and particle size. The oral bioavailability of three different formulations was compared in a dog model: a cosolvent-surfactant solution, a solid dispersion in a mixture of polyethylene glycol 3350 and polysorbate 80, and a dry blend of micronized drug with microcrystalline cellulose. In absence of a parenteral injection, the bioavailability of the solution was considered to be 100%, and the relative oral bioavailability of the three formulations was 100, 99.1, 9.8, respectively. Comparable bioavailability was obtained with the solid dispersion and the cosolvent-surfactant solution, both of which showed a 10-fold higher bioavailability than the dry blend. Thus, a 20 mg dose strength capsule containing the solid dispersion formulation was selected for clinical development. The selected solid dispersion system was physically and chemically stable for at least 16 months at 25 degrees C/60% RH. In conclusion, the bioavailability of a poorly water soluble drug was greatly enhanced using the solid dispersion formulation containing a water soluble polymer with a surface active agent.

[1]  A. Serajuddin,et al.  Improved dissolution of a poorly water-soluble drug from solid dispersions in polyethylene glycol: polysorbate 80 mixtures. , 1990, Journal of pharmaceutical sciences.

[2]  A. Serajuddin,et al.  Effect of vehicle amphiphilicity on the dissolution and bioavailability of a poorly water-soluble drug from solid dispersions. , 1988, Journal of pharmaceutical sciences.

[3]  H. Sunada,et al.  Influence of water-soluble polymers on the dissolution of nifedipine solid dispersions with combined carriers. , 1998, Chemical & pharmaceutical bulletin.

[4]  S. Riegelman,et al.  Pharmaceutical applications of solid dispersion systems. , 1971, Journal of pharmaceutical sciences.

[5]  A. Serajuddin,et al.  Solid dispersion of poorly water-soluble drugs: early promises, subsequent problems, and recent breakthroughs. , 1999, Journal of pharmaceutical sciences.

[6]  Tanuja Save,et al.  Studies on solid dispersions of nifedipine , 1992 .

[7]  K. Danjo,et al.  Preparation and Dissolution Behavior of Ethenzamide Solid Dispersions Using Various Sugars as Dispersion Carriers , 1997 .

[8]  Mohammed Jemal,et al.  Bioavailability enhancement of a poorly water-soluble drug by solid dispersion in polyethylene glycol-polysorbate 80 mixture. , 2004, International journal of pharmaceutics.

[9]  A. Gürsoy,et al.  The Preparation and Stability of Fast Release Furosemide – PVP Solid Dispersion , 1988 .

[10]  Diana Chow,et al.  Preformulation study of etoposide: II. Increased solubility and dissolution rate by solid-solid dispersions , 1995 .

[11]  N. Asakawa,et al.  Improvement of dissolution and oral absorption of ER-34122, a poorly water-soluble dual 5-lipoxygenase/cyclooxygenase inhibitor with anti-inflammatory activity by preparing solid dispersion. , 2002, Journal of pharmaceutical sciences.

[12]  Paul W. Buehler,et al.  Comparison of Oral Absorption and Bioavailability of Drugs Between Monkey and Human , 2002, Pharmaceutical Research.

[13]  G. Zuber,et al.  Investigation of formulation approaches to improve the dissolution of SB-210661, a poorly water soluble 5-lipoxygenase inhibitor , 1998 .

[14]  Ford Jl,et al.  The current status of solid dispersions. , 1986 .

[15]  J. Dressman,et al.  In vitro-in vivo correlations for lipophilic, poorly water-soluble drugs. , 2000, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[16]  I. Sugimoto,et al.  Stability and bioavailability of nifedipine in fine granules. , 1982, Chemical & pharmaceutical bulletin.

[17]  J. Dressman,et al.  Influence of physicochemical properties on dissolution of drugs in the gastrointestinal tract. , 1997, Advanced drug delivery reviews.

[18]  K R Morris,et al.  Structural properties of polyethylene glycol-polysorbate 80 mixture, a solid dispersion vehicle. , 1992, Journal of pharmaceutical sciences.

[19]  Hoo-Kyun Choi,et al.  Enhanced dissolution of furosemide by coprecipitating or cogrinding with crospovidone , 1998 .

[20]  A. Serajuddin,et al.  Physicochemical basis of increased bioavailability of a poorly water-soluble drug following oral administration as organic solutions. , 1988, Journal of pharmaceutical sciences.

[21]  K R Morris,et al.  Selection of solid dosage form composition through drug-excipient compatibility testing. , 1999, Journal of pharmaceutical sciences.

[22]  S. Varia,et al.  Study of phase behavior of poly(ethylene glycol)-polysorbate 80 and poly(ethylene glycol)-polysorbate 80-water mixtures. , 2000, Journal of pharmaceutical sciences.

[23]  R. Ibuki,et al.  Dissolution mechanism and rate of solid dispersion particles of nilvadipine with hydroxypropylmethylcellulose , 1997 .

[24]  N. Shah,et al.  Influence of dispersion method on dissolution rate and bioavailability of digoxin from triturations and compressed tablets II. , 1974, Journal of pharmaceutical sciences.

[25]  A. K. Taylor,et al.  Decrease in the rate of capsule dissolution due to formaldehyde from polysorbate 80 autoxidation. , 1984, Journal of pharmaceutical sciences.